Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Selective uptake of a DNA gyrase poison kills Mycobacterium tuberculosis

Photorhabdus noenieputensis (a gut microbiota symbiont of nematodes) produces a macrocyclic antibiotic, evybactin, that selectively kills Mycobacterium tuberculosis (Mtb). The Mtb membrane transporter BacA imports evybactin into the cell, where it binds to DNA gyrase and causes cell death.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Evybactin enters Mtb via BacA and binds to DNA gyrase.

References

  1. Kinsella, R. L. et al. Perspectives and advances in the understanding of tuberculosis. Annu. Rev. Pathol. 16, 377–408 (2021). This is a Review of tuberculosis.

    Article  CAS  Google Scholar 

  2. Lewis, K. The science of antibiotic discovery. Cell 181, 29–45 (2020). This Perspective describes the state of the art in the field and the promising approaches to antibiotic discovery.

    Article  CAS  Google Scholar 

  3. Imai, Y. et al. A new antibiotic selectively kills Gram-negative pathogens. Nature 576, 459–464 (2019). This paper describes the rationale for using Photorhabdus species to discover drug-like compounds.

    Article  CAS  Google Scholar 

  4. Gavrish, E. et al. Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2. Chem. Biol. 21, 509–518 (2014). This paper reports the discovery of a selective compound that targets the Clp protease.

    Article  CAS  Google Scholar 

  5. Quigley, J. et al. Novel antimicrobials from uncultured bacteria acting against Mycobacterium tuberculosis. mBio 11, 4 (2020). This paper reports the discovery of amycobactin, which selectively targets mycobacteria.

    Article  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Imai, Y. et al. Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis. Nat. Chem. Biol. https://doi.org/10.1038/s41589-022-01102-7 (2022).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Selective uptake of a DNA gyrase poison kills Mycobacterium tuberculosis. Nat Chem Biol 18, 1174–1175 (2022). https://doi.org/10.1038/s41589-022-01103-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-022-01103-6

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research